Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by reducing hunger signals in your brain and slowing stomach emptying, creating a powerful appetite-suppression effect that leads to consistent weight loss. Clinical trials show patients on semaglutide lose approximately 15% of their starting body weight over 68 weeks, though the timeline and pace depend on your unique metabolism and adherence to treatment.

Weight Loss During the First Month of Semaglutide

Most patients begin semaglutide at a low dose (0.25 mg weekly) to allow their body to adapt and minimize side effects. During this first four-week period, many people notice reduced appetite within days, though actual scale movement typically appears in week two or three. Initial weight loss often ranges from two to five pounds, though this varies significantly based on starting weight, calorie deficit, and individual response.

The first month establishes your baseline tolerance and sets the stage for dose escalation. PlexusDx's compounded semaglutide injection begins at $149 per month regardless of dose level—meaning your medication cost stays fixed as your dose increases. Some patients experience rapid early results due to water loss and reduced food intake, while others see gradual, steady progress that compounds over weeks.

Realistic Weight Loss Expectations Over Three to Six Months

By month three, most patients reach their therapeutic dose and experience peak appetite suppression. Weekly weight loss typically stabilizes at one to two pounds per week during this phase, resulting in eight to fifteen pounds lost over the three-month window. This pace assumes consistent lifestyle habits and gradual dose increases as prescribed by your provider.

Between months three and six, cumulative weight loss usually ranges from fifteen to thirty pounds for patients who maintain dietary discipline and moderate physical activity. The rate may slow slightly as your body adjusts to its new weight set-point, but semaglutide continues reducing hunger and food cravings. Plateaus are normal—they often signal your metabolism adapting, not a treatment failure.

Factors That Shape Your Individual Semaglutide Timeline

Your genetics significantly influence how quickly semaglutide works. PlexusDx's Precision Peptide Genetic Test identifies variants in the GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) genes that predict your peptide-pathway responsiveness. Patients with favorable genetic profiles may lose weight faster and require lower doses, while others benefit from understanding their genetic predisposition to inform realistic timelines.

Starting weight, age, insulin resistance, and existing medications all modulate semaglutide's effect. Patients with higher baseline weight often see faster absolute weight loss initially, though percentage-based losses may be similar. Concurrent lifestyle changes—increased protein intake, regular movement, sleep quality, and stress management—multiply semaglutide's effectiveness and accelerate results beyond medication alone.

What Happens When You Hit a Weight Loss Plateau

Plateaus typically occur after three to four months of consistent weight loss and reflect your body's metabolic adaptation to its new weight. During a plateau, semaglutide is still active—your appetite remains suppressed and calorie intake stays low—but the scale temporarily freezes. This is a sign to assess your current dose, review eating patterns, and often increase exercise intensity rather than assume the medication has stopped working.

PlexusDx providers monitor your progress and adjust semaglutide dosing or explore complementary options like compounded tirzepatide if plateaus persist. Many patients break through plateaus with modest dose increases or by adding structured resistance training. Understanding that plateaus are temporary and expected prevents discouragement and supports long-term adherence to your weight loss plan.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in my first month on semaglutide?

Most patients lose two to five pounds in month one as appetite decreases and fluid shifts occur. However, the first month focuses on dose tolerance rather than maximum weight loss. PlexusDx compounded semaglutide injection starts at $149/month, and your cost remains the same whether you're on 0.25 mg or your therapeutic dose.

What clinical evidence supports semaglutide's weight loss timeline?

The STEP trials demonstrated that patients on semaglutide 2.4 mg weekly lost approximately 15% of body weight (22 pounds average) over 68 weeks compared to 2.6% on placebo. Weekly weight loss typically reaches one to two pounds by weeks four through twelve once steady-state dosing is achieved, with cumulative results reaching 30+ pounds by six months in many patients.

Does PlexusDx offer genetic testing to predict my weight loss speed?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 49 peptides, including GLP1R and GIPR variants that predict how quickly semaglutide will work for you. This personalization helps your provider set realistic expectations and optimize your dosing strategy.

Is compounded semaglutide safe and effective for weight loss?

PlexusDx sources all semaglutide from licensed 503A compounding pharmacies that follow strict FDA guidelines, ensuring safety and consistency. Compounded semaglutide has identical active ingredients to brand products and produces the same clinical outcomes when dosed appropriately. However, compounded medications are not FDA-approved; they are created under specific patient prescriptions.

What if I'm not losing weight fast enough on semaglutide?

Slower-than-expected weight loss may indicate a subtherapeutic dose, lifestyle factors limiting results, or genetic variations in GLP1R responsiveness. Your PlexusDx provider can increase your semaglutide dose (your monthly cost stays flat at $149), explore your Precision Peptide genetic profile, or discuss compounded tirzepatide or dual-compound options to enhance results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves